Patents by Inventor Amy Hall

Amy Hall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8241674
    Abstract: Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: August 14, 2012
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Amy Hall, Anu Desai, Jeffrey S. Bland
  • Publication number: 20120189721
    Abstract: Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.
    Type: Application
    Filed: January 18, 2012
    Publication date: July 26, 2012
    Applicant: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Amy Hall, Anu Desai, Jeffrey S. Bland
  • Publication number: 20110021637
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on xanthohumol or isoxantohumol, or tetrahydro-isoalpha acids commonly found in hops.
    Type: Application
    Filed: April 6, 2010
    Publication date: January 27, 2011
    Applicant: METAPROTEOMICS, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Veera Konda, Amy Hall, Linda M. Pacioretty, Anu Desai
  • Patent number: 7736677
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on xanthohumol or isoxantohumol, or tetrahydro-isoalpha acids commonly found in hops.
    Type: Grant
    Filed: June 20, 2007
    Date of Patent: June 15, 2010
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, John G. Babish, Jeffrey S. Bland, Veera Konda, Amy Hall, Linda M. Pacioretty, Anu Desai
  • Patent number: 7718198
    Abstract: Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed.
    Type: Grant
    Filed: January 6, 2006
    Date of Patent: May 18, 2010
    Assignee: Metaproteomics, LLC
    Inventors: Matthew Tripp, Jeffrey S. Bland, Robert Lerman, Amy Hall, Veera Konda, Anu Desai
  • Publication number: 20090155382
    Abstract: Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.
    Type: Application
    Filed: February 13, 2008
    Publication date: June 18, 2009
    Applicant: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Amy Hall, Anu Desai, Jeffrey S. Bland
  • Publication number: 20080051466
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on isoalpha acids, commonly found in hops.
    Type: Application
    Filed: June 20, 2007
    Publication date: February 28, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Veera Konda, Amy Hall, Linda Pacioretty, Anu Desai
  • Publication number: 20080051465
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on xanthohumol or isoxantohumol, or tetrahydro-isoalpha acids commonly found in hops.
    Type: Application
    Filed: June 20, 2007
    Publication date: February 28, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Veera Konda, Amy Hall, Linda Pacioretty, Anu Desai
  • Publication number: 20080033056
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on xanthohumol or isoxantohumol, commonly found in hops.
    Type: Application
    Filed: June 20, 2007
    Publication date: February 7, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Veera Konda, Amy Hall, Linda Pacioretty, Anu Desai
  • Publication number: 20080031894
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on beta acids, commonly found in hops.
    Type: Application
    Filed: June 20, 2007
    Publication date: February 7, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Veera Konda, Amy Hall, Linda Pacioretty, Anu Desai
  • Publication number: 20080031982
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on tetrahydro-isoalpha acids, commonly found in hops.
    Type: Application
    Filed: June 20, 2007
    Publication date: February 7, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Veera Konda, Amy Hall, Linda Pacioretty, Anu Desai
  • Publication number: 20080031893
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on Acacia fractions, compounds, and extracts.
    Type: Application
    Filed: June 20, 2007
    Publication date: February 7, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Veera Konda, Amy Hall, Linda Pacioretty, Anu Desai
  • Publication number: 20080031986
    Abstract: Botanical compounds to modulate kinase activity are disclosed. The compounds and methods disclosed also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively. The compositions contain at least one fraction isolated or derived from hops or Acacia.
    Type: Application
    Filed: June 29, 2007
    Publication date: February 7, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Amy Hall, Veera Konda, Linda Pacioretty, Anu Desai
  • Publication number: 20080033057
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on hexahydro-isoalpha acids, commonly found in hops.
    Type: Application
    Filed: June 20, 2007
    Publication date: February 7, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Veera Konda, Amy Hall, Linda Pacioretty, Anu Desai
  • Publication number: 20080026088
    Abstract: Compounds and methods for protein kinase modulation for cancer treatment are disclosed. The compounds and methods disclosed are based on reduced isoalpha acids, commonly found in hops.
    Type: Application
    Filed: June 20, 2007
    Publication date: January 31, 2008
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Veera Konda, Amy Hall, Linda Pacioretty, Anu Desai
  • Publication number: 20070281045
    Abstract: Disclosed are botanically based compositions and methods useful for the treatment of metabolic syndrome and diabetes type 2. Compositions, kits, and methods are additionally disclosed for means to augment the activity of identified glucose and insulin regulating drugs.
    Type: Application
    Filed: December 7, 2006
    Publication date: December 6, 2007
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Amy Hall, Veera Konda, Linda Pacioretty
  • Publication number: 20070166418
    Abstract: Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed.
    Type: Application
    Filed: January 4, 2007
    Publication date: July 19, 2007
    Applicant: Metaproteomics, LLC
    Inventors: Matthew Tripp, Jeffrey Bland, Robert Lerman, Amy Hall, Veera Konda, Anu Desai
  • Publication number: 20070154576
    Abstract: Botanical compounds to modulate kinase activity are disclosed. The compounds and methods disclosed also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively. The compositions contain at least one fraction isolated or derived from hops or Acacia.
    Type: Application
    Filed: December 11, 2006
    Publication date: July 5, 2007
    Inventors: Matthew Tripp, John Babish, Jeffrey Bland, Amy Hall, Veera Konda, Linda Pacioretty, Anu Desai
  • Publication number: 20070042063
    Abstract: Botanical compounds to modulate kinase activity are disclosed. The compounds and methods disclosed also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively. The compositions contain at least one fraction isolated or derived from hops or Acacia.
    Type: Application
    Filed: August 9, 2006
    Publication date: February 22, 2007
    Inventors: Matthew Tripp, John Babish, Linda Pacioretty, Jeffrey Bland, Amy Hall, Veera Konda, Anu Desai
  • Publication number: 20070020352
    Abstract: Compositions of reduced isoalpha acids, vitamins and minerals are disclosed as well as methods of using the same for the treatment of autoimmune diseases. Additional combinations including other compounds are also contemplated. Synergistic properties and methods exploiting such synergy are also disclosed.
    Type: Application
    Filed: January 6, 2006
    Publication date: January 25, 2007
    Inventors: Matthew Tripp, Jeffrey Bland, Robert Lerman, Amy Hall, Veera Konda, Anu Desai